Patient focus
We put the needs and experiences of patients at the core of our mission and purpose, working to turn cells into powerful therapeutics.
Future of malignant and non-malignant hematological conditions
Our proprietary nicotinamide (NAM) technology leverages the properties of NAM to enhance and expand cells, creating allogeneic cell therapy products and candidates that are potentially curative for patients with hematologic and non-hematological conditions.
Dedicated team
We are pioneers with respected track records in cell therapy research and development, manufacturing and commercialization. We combine bold and creative pursuits in science with a passion for treating malignant and non-malignant hematological conditions so that patients can live longer, better lives.
